Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Dec 15, 2022
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common stock, $0.0001 par value
2022-12-14$0.39/sh+2,000$780→ 74,541 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.